Group Photo

SELECTED PUBLICATIONS


Computationally designed antibody-drug conjugates self-assembled via affinity ligands.

Nature Biomedical Engineering, 2019

Gupta N, Ansari A, Dhoke GV, Chilamari M, Sivaccumar J, Kumari S, Chatterjee S, Goyal R, Dutta PK, Samarla M, Mukherjee M, Sarkar A, Mandal SK, Rai V, Biswas G, Sengupta A, Roy S, Roy M, Sengupta S.


Transcellular transfer of nanomedicine

Nature Nanotechnology, 2019

Jang HL, Sengupta S


A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer

Nature Biomedical Engineering, 2018

Ashish Kulkarni, Vineethkrishna Chandrasekar, Siva Kumar Natarajan, Anujan Ramesh, Prithviraj Pandey, Jayashree Nirgud, Harshangda Bhatnagar, Driti Ashok, Amrendra Kumar Ajay,and Shiladitya Sengupta


Development of a facile antibody-drug conjugate platform for increased stability and homogeneity.

Chem Sci., 2017

Gupta N, Kancharla J, Kaushik S, Ansari A, Hossain S, Goyal R, Pandey M, Sivaccumar J, Hussain S, Sarkar A, Sengupta A, Mandal SK, Roy M ,Sengupta S.


Cancer nanomedicine: lessons for immuno-oncology.

Trends Cancer, 2017

Sengupta S.


Rationally designed 2-in-1 nanoparticles can overcome adaptive resistance in cancer

ACS Nano, 2016

Aaron Goldman, Ashish Kulkarni, Mohammad Kohandel, Prithvi Pandey, Poornima Rao, Siva Kumar Natarajan, Venkata Sabbisetti, Shiladitya Sengupta


Combining immune checkpoint inhibitors and kinase-inhibiting supramolecular therapeutics for enhanced anti-cancer efficacy

ACS Nano, 2016

Kulkarni A. A., Natarajan S. K., Chandrasekar V., Pandey P, Sengupta S.


Algorithm for designing nanoscale supramolecular therapeutics with increased anticancer efficacy

ACS Nano, 2016

Ashish Kulkarni, Prithvi Pandey, Poornima Rao, Ayaat Mahmoud, Aaron Goldman, Venkata Sabbisetti, Shashikanth Parcha, Siva Kumar Natarajan, Vineethkrishna Chandrasekar, Daniela Dinulescu, Sudip Roy, Shiladitya Sengupta


Reporter nanoparticle that monitors its anticancer efficacy in real time.

Proceedings of National Academy of Sciences U S A, 2016

Ashish Kulkarni, Poornima Rao, Siva Natarajan, Aaron Goldman, Venkata S. Sabbisetti, Yashika Khater, Navya Korimerla, Vineethkrishna Chandrasekar, Raghunath A. Mashelkar, and Shiladitya Sengupta


Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition

Nature Communication, 2015

Goldman A, Majumder B, Dhawan A, Ravi S, Goldman D, Kohandel M, Majumder PK, Sengupta S.


Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity.

Nature Communication, 2015

Biswanath Majumder, Ulaganathan Baraneedharan, Saravanan Thiyagarajan, Padhma Radhakrishnan, Harikrishna Narasimhan, Muthu Dhandapani, Nilesh Brijwani, Dency D. Pinto, Arun Prasath, Basavaraja U. Shanthappa, Allen Thayakumar, Rajagopalan Surendran, Govind K. Babu, Ashok M. Shenoy, Moni A. Kuriakose, Guillaume Bergthold, Peleg Horowitz, Massimo Loda, Rameen Beroukhim, Shivani Agarwal, Shiladitya Sengupta, Mallikarjun Sundaram & Pradip K. Majumder


Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype.

Nature Communication, 2015

Yamicia Connor, Sarah Tekleab, Shyama Nandakumar, Cherelle Walls, Yonatan Tekleab, Amjad Husain, Or Gadish, Venkata Sabbisetti, Shelly Kaushik, Seema Sehrawat, Ashish Kulkarni, Harold Dvorak, Bruce Zetter, Elazer R. Edelman & Shiladitya Sengupta


A cholesterol-tethered platinum ii-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity.

Proceedings of National Academy of Sciences U S A, 2012

Sengupta P, Basu S, Soni S, Pandey A, Roy B, Oh MS, Chin KT, Paraskar AS, Sarangi S, Connor Y, Sabbisetti VS, Kopparam J, Kulkarni A, Muto K, Amarasiriwardena C, Jayawardene I, Lupoli N, Dinulescu DM, Bonventre JV, Mashelkar RA, Sengupta S.


Novel cancer therapy through temporal targeting of both tumor cells and neovasculature using a unique nanoscale delivery system

Nature, 2005

Sengupta S, Eavarone D, Capila I, Zhao G, Watson N, Kiziltepe T, Sasisekharan R.





ALL PUBLICATIONS


Computationally designed antibody-drug conjugates self-assembled via affinity ligands.

Nature Biomedical Engineering, 2019

Gupta N, Ansari A, Dhoke GV, Chilamari M, Sivaccumar J, Kumari S, Chatterjee S, Goyal R, Dutta PK, Samarla M, Mukherjee M, Sarkar A, Mandal SK, Rai V, Biswas G, Sengupta A, Roy S, Roy M, Sengupta S.


Transcellular transfer of nanomedicine

Nature Nanotechnology, 2019

Jang HL, Sengupta S


Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance.

Science Signaling, 2019.

Goldman A, Khiste S, Freinkman E, Dhawan A, Majumder B, Mondal J, Pinkerton AB, Eton E, Medhi R, Chandrasekar V, Rahman MM, Ichimura T, Gopinath KS, Majumder P, Kohandel M, Sengupta S.


A Microfabricated Sandwiching Assay for Nanoliter and High-Throughput Biomarker Screening.

Small, 2019.

Bandaru P, Chu D, Sun W, Lasli S, Zhao C, Hou S, Zhang S, Ni J, Cefaloni G, Ahadian S, Dokmeci MR, Sengupta S, Lee J, Khademhosseini A.


Organ-on-a-Chip for Cancer and Immune Organs Modeling.

Advanced Healthcare Material, 2019.

Sun W, Luo Z, Lee J, Kim HJ, Lee K, Tebon P, Feng Y, Dokmeci MR, Sengupta S, Khademhosseini A.


Applications of nanotechnology for regenerative medicine; Healing tissues at the nanoscale.

Principles of regenerative medicine. 3rd ed. Academic Press; 2019.

Yang Y, Chawla A, Zhang J, Esa A, Jang HL*, Khademhosseini A


A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer

Nature Biomedical Engineering, 2018

Ashish Kulkarni, Vineethkrishna Chandrasekar, Siva Kumar Natarajan, Anujan Ramesh, Prithviraj Pandey, Jayashree Nirgud, Harshangda Bhatnagar, Driti Ashok, Amrendra Kumar Ajay,and Shiladitya Sengupta


A rationally designed multi-functional antibiotic for the treatment of drug-resistant acne.

J Invest Dermatol, 2018.

Ghosh S, Sinha M, Bhattacharyya A, Sadhasivam S, Megha J, Reddy S, Saini S, Singh H, Kumar D, Kaur SP, Mishra M, Usharani D, Ghosh S, Sengupta S.


Injectable shear thinning hydrogels for delivering osteogenic and angiogenic cells and growth factors.

Biomaterial Science, 2018.

Alarçin E, Lee TY, Karuthedom S, Mohammadi M, Brennan MA, Lee DH, Marrella A, Zhang J, Syla D, Zhang YS*, Khademhosseini A*, Jang HL


Synergistic interplay between the two major bone minerals, hydroxyapatite and whitlockite nanoparticles, for osteogenic differentiation of mesenchymal stem cells.

Acta Biomaterialia, 2018.

Cheng H, Chabok R, Guan X, Chawla A, Li Y, Khademhosseini A*, Jang HL*


Development of a facile antibody-drug conjugate platform for increased stability and homogeneity.

Chem Sci., 2017

Gupta N, Kancharla J, Kaushik S, Ansari A, Hossain S, Goyal R, Pandey M, Sivaccumar J, Hussain S, Sarkar A, Sengupta A, Mandal SK, Roy M ,Sengupta S.


Cancer nanomedicine: lessons for immuno-oncology.

Trends Cancer, 2017.

Sengupta S.


Evaluation of therapeutic potential of vb-001, a leave-on formulation, for the treatment of moderate adherent dandruff.

BMC Dermatol, 2017.

Bhattacharyya A, Jain N, Prasad S, Jain S, Yadav V, Ghosh S, Sengupta S.


3D printed anchoring sutures for permanent shaping of tissues.

MacromolBiosci, 2017.

Wei W, Li Y, Yang H, Nassab R, Shahriyari F, Akpek A, Guan X, Liu Y, Taranejoo S, Tamayol A, Zhang YS, Khademhosseini A*, Jang HL*.


Chondroitin sulfate-based biomineralizing surface hydrogels for bone tissue engineering.

ACS Appl Mater Interfaces, 2017.

Kim HD, Lee EA, An YH, Kim SL, Lee SS, Yu SJ, Jang HL, Nam KT, Im SG, Hwang NS.


Cold‐spray coating of hydroxyapatite on a three‐dimensional polyetheretherketone implant and its biocompatibility evaluated by in vitro and in vivo minipig model.

J Biomed Mater Res B Appl Biomater, 2017.

Lee JH*, Jang HL*, Lee KM, Baek HR, Jin K, Noh JH.


Biomimetic whitlockite inorganic nanoparticles-mediated in situ remodeling and rapid bone regeneration.

Biomaterials, 2017.

Kim HD*, Jang HL*, Ahn HY, Lee HK, Park J, Lee ES, Lee EA, Jeong YH, Kim DG, Nam KT, Hwang NS


Rapid continuous multimaterial extrusion bioprinting.

Advanced Material, 2017.

Liu W, Zhang YS, Heinrich MA, Ferrari FD, Jang HL, Bakht SM, Alvarez MM, Yang J, Li Y, Santiago G, Miri AK, Khoshakhlagh P, Prakash G, Cheng H, Guan X, Zhong Z, Ju J, Zhu G, Jin X, Shin SR, Dokmeci MR, Khademhosseini A.


Engineering vascularized and innervated bone biomaterials for improved skeletal tissue regeneration.

Materials Today, 2017.

Marrella A, Lee TY, Lee DH, Karuthedom S, Syla D, Chawla A, Khademhosseini A*, Jang HL*.


Development of nanomaterials for bone targeted drug delivery.

Drug Discovery Today, 2017.

Cheng H, Chawla A, Yang Y, Li Y, Zhang J, Jang HL*, Khademhosseini A*.


Development of hydrogels for regenerative engineering.

Biotechnol J, 2017.

GuanX, Avci-Adali M, Alarçin E, Cheng H, Kashaf SS, Li Y, Chawla A, Jang HL*, Khademhosseini A*.


Rationally designed 2-in-1 nanoparticles can overcome adaptive resistance in cancer

ACS Nano, 2016

Aaron Goldman, Ashish Kulkarni, Mohammad Kohandel, Prithvi Pandey, Poornima Rao, Siva Kumar Natarajan, Venkata Sabbisetti, Shiladitya Sengupta


Combining immune checkpoint inhibitors and kinase-inhibiting supramolecular therapeutics for enhanced anti-cancer efficacy

ACS Nano, 2016

Kulkarni A. A., Natarajan S. K., Chandrasekar V., Pandey P, Sengupta S.


Algorithm for designing nanoscale supramolecular therapeutics with increased anticancer efficacy

ACS Nano, 2016

Ashish Kulkarni, Prithvi Pandey, Poornima Rao, Ayaat Mahmoud, Aaron Goldman, Venkata Sabbisetti, Shashikanth Parcha, Siva Kumar Natarajan, Vineethkrishna Chandrasekar, Daniela Dinulescu, Sudip Roy, Shiladitya Sengupta


Heterogeneity and antibiotic resistance in Propionibacterium acnes strains and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.

Dermatol Ther, 2016.

Sadhasivam S, Sinha M, Saini S, Kaur SP, Gupta T, Sengupta S, Ghosh S, Sardana K.


Boosting clinical translation of nanomedicine.

Nanomedicine, 2016.

Jang HL, Zhang YS, Khademhosseini A.


Recreating composition, structure, functionalities of tissues at nanoscale for regenerative medicine.

Regen Med, 2016.

Alarçin E, Guan X, Kashaf SS, Elbaradie K, Jang HL*, Khademhosseini A*


Graphene-based materials for tissue engineering.

Adv Drug Deliv Rev, 2016.

Shin SR, Li YC, Jang HL, Khoshakhlagh P, Akbari M, Nasajpour A, Zhang YS, Tamayol A, Khademhosseini A.


Dynamic microenvironment induces phenotypic plasticity of esophageal cancer cells under flow.

Scientific Report, 2016.

Calibasi Kocal G, Güven S, Foygel K, Goldman A, Chen P, Sengupta S, Paulmurugan R, Baskin Y, Demirci U


Supramolecular fusion nanotherapeutic- mediated synergistic inhibition of pi3k and mek pathways.

AACR Annual Meeting, 2016, New Orleans, LA.

Chandrasekar V, Natarajan SK, Sengupta S, Kulkarni A. A.


Sustained inhibition of cmet-vegfr2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer.

Nanomedicine, 2016.

Kulkarni AA, Vijaykumar VE, Natarajan SK, Sengupta S, Sabbisetti VS


Rationally designed 2-in-1 nanoparticles can overcome adaptive resistance in cancer.

ACS Nano, 2016.

Goldman A, Kulkarni AA, Kohandel M, Pandey PR, Rao P, Natarajan S, Sabbisetti VS, Sengupta S.


Algorithm for designing nanoscale supramolecular therapeutics with increased anticancer efficacy.

ACS Nano, 2016.

Kulkarni AA, Pandey P, Rao P. S., Wyant G., Mahmoud A, Goldman A, Kotamraju VR, Ruoslahti E, Dinulescu D, Roy S, Sengupta S


Combining immune checkpoint inhibitors and kinase-inhibiting supramolecular therapeutics for enhanced anti-cancer efficacy.

ACS Nano, 2016.

Kulkarni AA, Natarajan SK, Chandrasekar V, Pandey P, Sengupta S.


Reporter nanoparticle that monitors its anticancer efficacy in real time.

Proceedings of National Academy of Sciences U S A, 2016.

Kulkarni AA, Rao P, Natarajan S, Goldman A, Sabbisetti V, Khater Y, Korimerla N, Mashelkar R, Sengupta S.


Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effects.

Scientific Report, 2016.

Molavian HR, Goldman A, Phipps CJ, Kohandel M, Wouters BG, Sengupta S, Sivaloganathan S.


Notch-jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype.

J R Soc Interface, 2016.

Boareto M, Jolly MK, Goldman A, Pietilä M, Mani SA, Sengupta S, Ben-Jacob E, Levine H, Onuchic JN.


Antibiotic-resistant acne: getting under the skin.

SeminCutan Med Surg, 2016.

Sinha M, Sadhasivam S, Bhattacharyya A, Jain S, Ghosh S, Arndt KA, Dover JS, Sengupta S.


In vitro and in vivo evaluation of whitlockite biocompatibility: comparative study with hydroxyapatite and β-tricalcium phosphate.

Advanced Healthcare Material, 2016.

Jang HL*, Zheng GB*, Park J, Kim DH, Baek HR, Lee HK, Lee K, Han HN, Lee CK, Hwang NS, Lee JH, Nam KT.


Supramolecular nanoparticles that target mapk pathway synergizes with immune checkpoint inhibitor in melanoma

AACR Annual Meeting, Philadelphia, PA, 2015.

Kulkarni AA, Sabbisetti V, Sengupta S.


Engineering of supramolecular taxane nanoparticles by computationally modeling drug-lipid bilayer interactions.

Experimental Biology Meeting, 2015, Boston, MA.

Kulkarni A, Pandey P, Rao P, Goldman G, Roy S, Sengupta S


Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition.

Nature Communication, 2015.

Goldman A. Majumder B, Dhawan A, Ravi S, Goldman D, Kohandel M, Majumder MK, Sengupta S.


Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity.

Nature Communication, 2015.

Majumder B, Baraneedharan U, Thiyagarajan S, Radhakrishnan P, Narasimhan H, Dhandapani M, Brijwani N, Pinto DD, Prasath A, Shanthappa BU, Thayakumar A, Surendran R, Babu G, Shenoy AM, Kuriakose MA, Bergthold G, Horowitz P, Loda M, Beroukhim R, Agarwal S, Sengupta S*, Sundaram M*, Majumder PK*.


Physical nanoscale conduit-mediated communication between tumor cells and the endothelium modulates endothelial phenotype.

Nature Communication, 2015.

Connor Y, Tekleab S, Nandakumar S, Walls C, Tekleab Y, Husain A, Gadish O, Sabbisetti V, Kaushik S, Sehrawat S, Kulkarni A, Dvorak H, Zetter B, Edelman E, Sengupta S.


Nano-hydroxyapatite modulates osteoblast lineage commitment by stimulation of DNA methylation and regulation of gene expression.

Biomaterials, 2015.

Ha SW, Jang HL, Nam KT, Beck GR.


Hybrid Z-scheme using photosystem I and BiVO4 for hydrogen production.

Advanced Functional Material, 2015.

Kim Y, Shin D, Chang WJ, Jang HL, Lee CW, Lee HE, Nam KT


Biofunctionalized ceramic with self-assembled networks of nanochannels.

ACS Nano, 2015.

Jang HL, Lee K, Kang CS, Lee HK, Ahn HY, Jin K, Park S, Kim SC, Yang TY, Jeong HY, Park J, Kim JH, Shin SA, Han HN, Oh KH, Lee H, Hong KS, Lim J, Snead LM, Xu J, Nam KT.


Phase transformation from hydroxyapatite to the secondary bone mineral, whitlockite.

J Mater Chem B, 2015.

Jang HL, Lee HK, Jin K, Ahn H, Lee H, Nam KT.>


Anti-platelet agents augment cisplatin nanoparticle cytotoxicity by enhancing tumor vasculature permeability and drug delivery.

Nanotechnology, 2014.

Pandey A, Sarangi S, Chien K, Sengupta P, Papa AL, Basu S, Sengupta S.


Targeting chemotherapy induced adaptive resistance using hybrid nanoparticles (LB577).

The FASEB Journal, 2014.

Kulkarni A, Rao P, Goldman A, Sengupta S.


Computationally-inspired engineering of supra-molecular taxane nanoparticles.

Cancer Research, 2014.

Kulkarni AA, Rao P, Goldman A, Sengupta S.


Clinical translational challenges in nanomedicine.

MRS Bull, 2014.

Sengupta S.


Sequential application of a cytotoxic nanoparticle and a pi3k-inhibitor enhances anti-tumor efficacy.

Cancer Research, 2014.

Pandey A, Kulkarni A, Roy B, Goldman A, Sarangi S, Sengupta P, Phipps C, Kopparam J, Oh M, Basu S, Kohandel M, Sengupta S.


Hydrated Manganese (II) Phosphate (Mn3(PO4)2-3H2O) as a water oxidation catalyst.

J Am Chem Soc, 2014.

Jin K, Park J, Lee J, Yang KD, Pradhan GK, Sim U, Jeong D, Jang HL, Park S, Kim D, Sung N, Kim SH, Han S, Nam KT.


PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic.

Cell Oncol, 2013.

apa A, Sidiqui A, Balasubramanian SUA, Sarangi S, Luchette M, Sengupta S, Harfouche R.


Supramolecular nanoparticles that target phosphatidylinositol-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy.

Cancer Research, 2013.

Kulkarni AK, Roy B, Rao PS, Wyant GA, Mahmoud A, Ramachandran M, Sengupta P, Goldman A, Kotamraju VR, Basu B, Mashelkar RA, Ruoslahti E, Dinulescu DM, Sengupta S.


P2Y12 Receptor inhibition augments cytotoxic effects of cisplatin in breast cancer.

Med. Oncol,2013.

Sarangi S, Pandey A, Papa AL, Sengupta P, Kopparam J, Dadwal U, Basu S, Sengupta S.


Design principles for clinical efficacy of cancer nanomedicine: a look into the basics.

ACS Nano,2013.

Sengupta S, Kulkarni A.


Rationally designed oxaliplatin nanoparticle for enhanced antitumor efficacy.

Nanotechnology, 2012.

Paraskar A, Soni S, Roy B, Papa AL, Sengupta S.


Revisiting whitlockite, the second most abundant biomineral in bone: nanocrystal synthesis in physiologically relevant conditions and biocompatibility evaluation.

ACS Nano,2013.

Jang HL, Jin K, Lee J, Kim Y, Nahm SH, Hong KS, Nam KT.


In vitro and in vivo evaluation of the bioactivity of hydroxyapatite coated polyetheretherketone biocomposites created by cold spray technology.

Acta Biomater,2013.

Lee JH*, Jang HL*, Lee KM, Baek H, Jin K, Hong KS, Noh JH, Lee H.


Mechanistic studies of gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells.

BMC Cancer, 2012.

Papa AL, Basu S, Sengupta P, Banerjee D, Sengupta S, Harfouche R


Intercellular transfer between metastatic breast cancer and the endothelium mediated by tunneling nanotubes.

Cancer Research, 2012.

Connor YD, Tekleab S, Gill NK, Bharat D, Lloyd T, Walls CR, Sengupta S.


A cholesterol-tethered platinum ii-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity.

Proceedingsof National Academy of Sciences U S A, 2012.

Sengupta P, Basu S, Soni S, Pandey A, Oh M, Chin KT, Paraskar AS, Roy B, Sarangi S, Connor Y, Sabbisetti V, Kopparam J, Amarasiriwardena C, Jayawardene I, Lupoli N, Dinulescu DM, Bonventre JV, Mashelkar RA, Sengupta S.


Insulin-like growth factors promote vasculogenesis in embryonic stem cells.

PLoS One,2012.

Piecewicz SM, Pandey A, Roy B, Hua Xiang S, Zetter BR, Sengupta S


Rationally engineered polymeric cisplatin nanoparticles for improved antitumor efficacy.

Nanotechnology, 2011.

Paraskar A, Soni S, Basu S, Amarasiriwardena CJ, Lupoli N, Srivats S, Roy RS, Sengupta S.


Quantitative model for efficient temporal targeting of tumor cells and neovasculature.

Comput Math Methods Med, 2011.

Kohandel M, Haselwandter C, Kardar M, Sengupta S, Sivaloganathan S.


Cancer, signal transduction and nanotechnology.

Current Drug Deliv, 2011.

Sengupta P, Basu S, Sengupta S.


The dynamic glycome microenvironment and stem cell differentiation into vasculature.

Stem Cells Dev, 2011.

Piecewicz S, Sengupta S.


Emerging technologies for enabling proangiogenic therapy.

Nanotechnology, 2011.

Roy RS, Roy B, Sengupta S


Nanoparticles in cancer chemotherapy

Nanoparticles in translational science and medicine,Progress in molecular biology and translational science: Waltham, MA: Academic Press. 2011.

Banerjee D, Sengupta S.


Nanotechnology-mediated targeting of tumor angiogenesis.

Vasc Cell, 2011.

Banerjee D, Harfouche R, Sengupta S


Harnessing structure-activity relationship to engineer a novel cisplatin nanoparticle for improved antitumor efficacy.

Proceedingsof National Academy of Sciences U S A. 2010.

Paraskar A, Chin KT, Chaudhuri P, Muto KW, Berkowitz J, Handlogten MW, Alves NJ, Bilgicer B, Dinulescu DM, Mashelkar RA, Sengupta S


The Bittersweet Promise of Glycobiology.

Biomarkers: In Medicine, Drug Discovery, and Environmental Health. Hoboken N.J.: Wiley Press, 2010.

Chaudhuri P, Harfouche R, Sengupta S.


Coupling growth factor engineering with nanotechnology for therapeutic angiogenesis.

Proceedings of National Academy of Sciences U S A, 2010.

Sinha Roy R, Soni S, Harfouche R, Vasudevan P, Holmes O, de Jonge H, Rowe A, Paraskar A, Hentschel DM, Gherardi E, Mashelkar RA, Sengupta S.


Modeling interactions between endothelial cells and metastatic breast cancer cells in a three-dimensional culture.

AACR 101st Annual Meeting, Washington, DC 2010.

Connor Y, Harfouche R, Liu C, Oh M, Sengupta S.


Integrating novel protein engineering and nanotechnology for therapeutic angiogenesis.

Experimental Biology Meeting, 2010. Published in FASEBJ, 2010.

Sinha-Roy R, Soni S, Harfouche R, Vasudevan PR, Paraskar A, Sengupta S.


Ranking chemical structures for drug discovery: a new machine learning approach.

J Chem Inf Model, 2010.

Agarwal S, Dugar D, Sengupta S.


Shape effect of carbon nanovectors on angiogenesis.

ACS Nano. 2010.

Chaudhuri P, Harfouche R, Soni S, Hentschel DM, Sengupta S.


Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma.

Nanotechnology, 2010.

Chaudhuri P, Soni S, Sengupta S.


Simple large-scale synthesis of hydroxyapatite nanoparticles: in situ observation of crystallization process.

Langmuir, 2010.

Kim DW, Cho I, Kim JY, Jang HL, Han GS, Ryu H, Shin H, Jung HS, Kim H, Hong KS.


Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy.

Proceedings of National Academy of Sciences U S A, 2009.

Basu S, Harfouche R, Soni S, Chimote G, Mashelkar RA, Sengupta S.


Glycome and transcriptome regulation of vasculogenesis.

Circulation, 2009.

Harfouche R, Hentschel D, Piecewicz, Basu S, Print C, Eavarone D, Kiziltepe T, Sasisekharan R, Sengupta S.


Emerging innovation practices and policies for the health-care needs of resource-poor people.

Global Forum Update on Research for Health, 2009.

Mashelkar RA, Patwardhan B, Sengupta S.


Fullerenol-cytotoxic conjugates for cancer chemotherapy.

ACS Nano, 2009.

Chaudhuri P, Paraskar A, Soni S, Mashelkar RA, Sengupta S.


Angiogenesis.

Drug Screening Methods. New Delhi, India: Jaypee Brothers Medical Publishers, 2009.

Sengupta S.


Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis.

Angiogenesis, 2009.

Harfouche R, Basu S, Soni S, Hentschel D, Mashelkar RA, Sengupta S.


A novel embryonic stem cell differentiation system for high-throughput antiangiogenesis screening.

FASEB J, 2009.

Piecewizc S, Harfouche R, Hentschel D, Basu S, Sengupta S.


Targeting oncogenic signaling pathways by exploiting nanotechnology.

Cell Cycle, 2009.

Basu S, Chaudhuri P, Sengupta S.


Searching for glycomics role in vasculogenesis.

Bioinformatics, 2008.

Sorathyia A, Jucikas T, Piecewicz S, Sengupta S, Lio P.


Exploiting nanotechnology to target cancer.

Br J Cancer, 2007.

Sengupta S, Sasisekharan R.


Chemical genetic analysis of glycome regulation in vasculogenesis.

Experimental Biology Conference, 2007.

Piecewicz S, Sengupta S, Hentschel DM.


Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system.

Nature, 2005.

Sengupta S, Eavarone DA, Capila I, Zhao G, Watson N, Kiziltepe T, Sasisekharan R.


Nitric oxide modulates hepatocyte growth factor induced angiogenesis.

Angiogenesis, 2004.

Sengupta S, Sellers LA, Gherardi E, Sasisekharan R, Fan TP.


Modulating angiogenesis- the yin and the yang in ginseng.

Circulation, 2004.

Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW, Yeung HW, Wong RNS, Sasisekharan R, Fan TP.


Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation.

FASEB J, 2004.

Johnson NA, Sengupta S, Saidi SA, Lessan K, Charnock-Jones SD, Scott L, Stephens R, Freeman TC, Tom BDM, Harris M, Denyer G, Sundaram M, Sasisekharan R, Smith SK, Print CG.


A dual color fluorescence imaging-based system for the dissection of antiangiogenic and chemotherapeutic activity of molecules.

FASEB J, 2004.

Sengupta S, Kiziltepe T, Sasisekharan R.


Delivery of therapeutic levels of heparin and low molecular weight heparin through a pulmonary route.

Proceedingsof National Academy of Sciences U S A, 2004.

Qi Y, Zhao G, Liu D, Shriver Z, Sundaram M, Sengupta S, Venkataraman G, Langer R, Sasisekharan R.


Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor.

ArteriosclerThrombVasc Biol, 2003.

Sengupta S, Gherardi E, Sellers LA, Sasisekharan R, Fan TP.


Thymidine phosphorylase induces angiogenesis in vitro and in vivo: an evaluation of possible mechanisms.

Br J Pharmacol. 2003

Sengupta S, Sellers LA, Matheson HB, Fan TP.


Targeting of mitogen activated protein kinases and phosphatidylinositol 3 kinase inhibits hepatocyte growth factor/scatter factor-induced angiogenesis.

Circulation, 2003.

Sengupta S, Seller LA, Li R, Zhao G, Gherardi E, Sasisekharan R, Fan TP.


Cyclooxygenase-2-selective non-steroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.

Cancer Research, 2003.

Sengupta S, Sellers LA, Cindrova T, Skepper JN, Gherardi E, Sasisekheran R, Fan TP.


A study of the signaling mechanisms of selected angiogenic promoters.

University of Cambridge, 2002.

Sengupta S.


Encapsulation in cationic liposomes enhances antitumour efficacy and reduces the toxicity of etoposide, a topo-isomerase ii inhibitor.

Pharmacology, 2001.

Sengupta S, Tyagi P, Chandra S, Kochupillai V, Gupta SK.


Angiogenesis: Concepts and research methodologies.

Pharmacology and Therapeutics in the New Millennium. New Delhi, India: Springer, 2001.

Sengupta S, Gupta S K.


Autoimmune diseases.

Blakemore C, Jennett S, editors. The Oxford Companion to the Body. Oxford UK: Oxford University Press, 2001.

Sengupta S, Fan T-P D.


Immunity.

The Oxford Companion to the Body. Oxford, UK: Oxford University Press, 2001.

Sengupta S, Fan T-P D.


Etoposide encapsulated in positively charged liposomes: pharmacokinetic studies in mice and formulation stability studies.

Pharmacol Res, 2000.

Sengupta S, Tyagi P, Velpandian T, Gupta Y K, Gupta S K.


Anti-inflammatory activity and pharmacokinetic profile of a new parenteral formulation of nimesulide.

Pharmacol Res,1999.

Gupta SK, Bhardwaj RK, Tyagi P, Sengupta S, Velpandian T.


Expression of inducible and neuronal nitric oxide synthase in 20-methyl cholanthrene (20-mca) induced fibrosarcoma.

Ind J Pharmacol, 1999.

Sengupta S, Sanyal M, Kochupillai V, Gupta SK.


Evaluation of the antitumour activity of liposomal formulations of etoposide against choriocarcinoma xenografts in balb/c nu/nu mice.

Pharm PharmacolCommun, 1999.

Tyagi P, Sengupta S, Velpandian T, Gupta Y K, Kochupillai V, Gupta SK.


Analgesic efficacy and pharmacokinetics of topical nimesulide gel in healthy human volunteers: double-blind comparison with piroxicam, diclofenac and placebo.

Eur J Clin Pharmacol, 1998.

Sengupta S, Velpandian T, Kabir SR, Gupta SK.


Preventive effect of chyavanprash against steroid induced cataract in the developing chick embryo.

Phytother Res, 1998.

Velpandian T, Mathur P, Sengupta S, Gupta SK.


Comparative analgesic efficacy of nimesulide and diclofenac gels after topical application on the skin.

Skin Pharmacol Appl Skin Physiol, 1998.

Sengupta S, Velpandian T, Sapra P, Mathur P, Gupta SK.


Influence of piperine on nimesulide induced antinociception.

Phytother Res, 1998.

Gupta SK, Velpandian T, Sengupta S, Mathur P, Sapra P.


Comparative analgesic activity of nimesulide and diclofenac by intramuscular route: correlation with pharmacokinetic profile of nimesulide.

Pharmacology, 1998.

Gupta SK, Velpandian T, Mathur P, Sengupta S.


Anti-inflammatory activity of topical nimesulide gel in various experimental models.

Inflamm Res, 1996.

Gupta SK, Prakash J, Awor L, Joshi S, Velpandian T, Sengupta S.